BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-143@pharmaconomics
DTSTAMP:20260707T050529Z
DTSTART;VALUE=DATE:20250930
DTEND;VALUE=DATE:20251001
SUMMARY:NVS Approval — Rhapsido
DESCRIPTION:A final FDA approval decision on Rhapsido for its lead indication is expected Sep 30\, 2025.\n\nPrimary source: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218436\n\nTrack it: https://www.pharmaconomics.com/e/143
URL:https://www.pharmaconomics.com/e/143
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:NVS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR